HAVCR2 and glioblastoma: A study by Ni and colleagues demonstrated that patients with glioblastoma tumors that displayed high expression scores for galectin-9 and TIM-3 had significantly lower survival than patients with tumors with low expression scores of galectin-9 and TIM-3 [72].